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Mini abstract (45 words max) 26 
This analysis assessed whether seasonal change in 25-hydroxyvitamin D  concentration was associated with 27 
bone resorption, as evidenced by serum parathyroid hormone and c-telopeptide concentrations. The main 28 
finding was that increased seasonal fluctuation in 25-hydroxyvitamin D was associated with  increased levels of 29 
parathyroid hormone and c-telopeptide. 30 
31 
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 32 
Abstract  33 
Purpose 34 
It is established that adequate 25-hydroxyvitamin D (25(OH)D, vitamin D) concentration is required 35 
for healthy bone mineralisation.  It is unknown whether seasonal fluctuations in 25(OH)D also impact 36 
on bone health. If large seasonal fluctuations in 25(OH)D were associated with increased bone 37 
resorption this would suggest a detriment to bone health. Therefore, this analysis assessed whether 38 
there is an association between seasonal variation in 25(OH)D and bone resorption.  39 
Methods 40 
The participants were n=279 Caucasian and n=88 South Asian women (mean (± SD) age 48.2y (14.4) 41 
who participated in the longitudinal D-FINES (Diet, Food Intake, Nutrition and Exposure to the Sun 42 
in Southern England) study (2006-2007). The main outcomes were serum 25(OH)D, serum 43 
parathyroid hormone (sPTH) and serum C-telopeptide of collagen (sCTX), sampled once per  season 44 
for each participant. 45 
Results    46 
Non-linear mixed modelling showed the (amplitude/mesor) ratio for seasonal change in log 25(OH)D 47 
to be predictive of log sPTH(estimate=0.057, 95% CI (0.051, 0.063), p < 0.0001)  Therefore, 48 
individuals with a higher seasonal change in log 25(OH)D, adjusted for overall log 25(OH)D 49 
concentration, showed increased levels of log sPTH.  There was a corresponding significant ability to 50 
predict the range of seasonal change in log25(OH)D  through the level of sCTX. Here the 51 
corresponding parameter statistics were: (estimate=0.528, 95% CI (0.418, 0.638), p=<0.0001).  52 
 53 
 54 
THE COPYRIGHT OF THIS VERSION OF THE ARTICLE IS THAT OF THE AUTHORS 
 
4 
 
 55 
Conclusions 56 
These findings suggest a possible detriment to bone health via increased levels of  sPTH and sCTX in 57 
individuals with a larger seasonal change in 25(OH)D concentration.  Further larger cohort studies are 58 
required to further investigate these preliminary findings. 59 
Key words 25-hydroxyvitamin D, bone resorption, c-telopeptide, parathyroid hormone, circannual 60 
rhythm, seasonal variation 61 
62 
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Introduction   63 
Globally, it has been shown that 25-hydroxyvitamin D (25(OH)D, vitamin D) concentration decreases 64 
with increasing geographical latitude [1].  Poor 25(OH)D status in Western societies has been 65 
associated with increased risk of chronic diseases such as osteoporosis, heart disease, cancer and 66 
diabetes as well as infectious and autoimmune diseases [2].  Due to their high Northern latitude, the 67 
prevalence of vitamin D deficiency has been shown to be high in individuals living in Europe [3] and 68 
Canada [4]. The seasonal variability in UVB radiation at higher latitudes also leads to noticeable 69 
seasonal variation in serum 25(OH)D concentration in individuals in these countries [5, 6].  Indeed, 70 
these seasonal differences are large compared to that of rural dwelling humans living closer to the 71 
equator [7].   72 
The situation is further complicated by the inter-individual variation in seasonal serum 25(OH)D 73 
within populations [8, 9]. Some individuals show far larger changes in serum 25(OH)D concentration 74 
than others across seasons. The reasons for these individual differences are not clear, but differences 75 
in sun exposure behaviour [8, 9], ethnicity [8-10], and clothing style[8]  may be responsible. Recent 76 
work in premenopausal UK women has shown that intra individual (e.g. seasonal) factors are as 77 
important as inter-individual factors in determining vitamin D status [8]. The few studies that have 78 
investigated seasonal changes in 25(OH)D concentration have found that South Asians [8-10] and 79 
older people from all ethnic groups [11, 12] show less pronounced seasonal variation in their 80 
25(OH)D concentration than other population sub-groups including younger adults and Caucasians.  81 
Large seasonal changes in 25(OH)D concentration may have consequences for the activity of the 82 
hydroxylase enzymes that control vitamin D metabolism. These enzymes include 1-hydroxylase (CYP 83 
27B1), which catalyses the conversion of the substrate 25(OH)D to 1,25dihydroxyvitamin D 84 
[1,25(OH)2D] and 24-hydroxylase (CYP24A1) which catalyses 25(OH)D to 24,25dihydroxyvitamin 85 
D [24,25(OH)2D] and 1,25(OH)2D to 1,24,25trihydroxyvitamin D [1,24,25(OH)3D]. The activity of 86 
the 1-hydroxylase enzyme is readily affected by changes in its 25(OH)D substrate.  This is because, 87 
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unlike many other enzymes, it is working well below its Michaelis-Menten constant (Km) at 88 
physiological concentrations of 25(OH)D. Therefore, large seasonal fluctuations in 25(OH)D 89 
substrate could cause large changes in the activity of the 1-hydroxylase enzyme [13]. In addition, 90 
theoretically, a long term decline in levels over the course of the year will not allow the desired level 91 
of 1,25(OH) 2D to be achieved until the decline finishes [14]. This suggests that individuals with large 92 
seasonal change in 25(OH)D concentration may have sub-optimal 1,25(OH)2D concentration for 93 
much of the year. In support of this, a recent study assessing seasonal changes in serum 25(OH)D and 94 
1,25(OH)2D concentrations in a Norwegian population (62
o
N) suggests that, at least in some 95 
individuals, circulating 1,25(OH)2D concentration does fluctuate by season [15], and mirrors 96 
fluctuation in 25(OH)D concentration [12]. It must be borne in mind that the level of 1-hydroxylase 97 
enzyme is also important in determining 1,25 (OH)2D concentration.  Indeed, this enzyme can be up 98 
regulated in the kidney, which leads to increases 1,25 (OH)D2D concentration in the plasma, but not 99 
other tissues.  Thus, 1,25 (OH)D2D status may vary between plasma and other tissues. 100 
 101 
There is no evidence to date as to whether regular large seasonal changes in 25(OH)D concentration 102 
have any effect on health. There has been some suggestion of potential harm, however, based on 103 
findings of increased risk of prostate and pancreatic cancers [16, 17] and findings of increased 104 
mortality [18] in individuals with high vitamin D status. It has been proposed that these detrimental 105 
effects could be due to seasonal changes in 25(OH)D rather than high 25(OH)D itself [14]. This is 106 
because individuals with high serum 25(OH)D concentrations tend to be those who show the most 107 
seasonal change in 25(OH)D. They are therefore potentially susceptible to the detrimental 108 
perturbations in the activity of the hydroxylase enzymes described above. This intriguing hypothesis 109 
proposed by Vieth [14] to explain the increased cancer risk begs the question as to whether seasonal 110 
fluctuation or ‘cycling’ of 25(OH)D could also be detrimental to other aspects of health. Indeed, a 111 
recent study suggested flares in the autoimmune disease systemic lupus erythematosis (SLE) may be 112 
precipitated by large changes in vitamin D status [19]. This finding suggests the effects of seasonal 113 
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changes in 25(OH)D may have more widespread implications for health than just cancer risk. It is 114 
unknown whether these large seasonal fluctuations in 25(OH)D may have an impact on bone health. 115 
The paracrine and autocrine effects of 1,25(OH)2D, produced locally in bone cells by 1-hydroxylase 116 
from 25(OH)D, have been recently elucidated [20, 21]. However, not enough is currently known 117 
about hydroxylase enzyme activity in bone cells to assess whether fluctuations in the 25(OH)D 118 
substrate would have any detriment on their ability to produce 1,25(OH)2D in the correct quantities.  119 
Indeed, in bone cells the 1-hydroxylase and 24-hydroxylase have been found to be positively coupled, 120 
unlike in kidney cells where they are inversely coupled [22].   121 
This paracrine and autocrine vitamin D activity is important for many bone cell processes, including 122 
mineralisation [23] and regulating osteoclast differentiation and activity [24]. It is unknown whether 123 
seasonal fluctuations in 25(OH)D concentration could cause adverse perturbations in this regulation, 124 
and thus be detrimental to bone health. Some studies show that bone markers show seasonal variation 125 
[25], but other studies do not [26]. It is unknown whether people showing a larger change in 25(OH)D 126 
over the course of a year show increased bone turnover in comparison to those with a smaller change 127 
in 25(OH)D. This study aimed to assess whether there is an association between bone resorption and 128 
the amount of seasonal change in 25(OH)D concentration. It was hypothesised that individuals 129 
showing a high degree of seasonal cycling of 25(OH)D would show increased bone resorption, as 130 
evidenced by both increased serum c-telopeptide [sCTX] and serum parathyroid hormone [sPTH] 131 
concentration. 132 
133 
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Methods  134 
Study Design 135 
Data from n =367 women (South Asian, n =88 and Caucasian, n =279) who took part in the 2006-136 
2007 D-FINES (Vitamin D, Food Intake, Nutrition and Exposure to Sunlight in Southern England) 137 
study [8] were analysed. Only participants who had no diagnosis of any disorder of calcium 138 
homeostasis, who were not peri-menopausal, or who were not currently taking any medication likely 139 
to affect bone, calcium or vitamin D metabolism were included in the study. Women who had been 140 
taking vitamin D supplements or cod liver oil supplements were excluded or asked to refrain from 141 
their use 3 months before and during the 12 months of the study. Further details of subject recruitment 142 
and D-FINES study background information can be found in Darling et al (2012) [8].  143 
During D-FINES, subjects had blood taken between 0800 and 1000 hours in four seasons (summer, 144 
autumn, winter and spring) for determination of 25(OH)D and sPTH concentration. Each participant 145 
visited once in each seasonal period, thus the actual visit date varied by participant. The summer visit 146 
period spanned June to August 2006 whilst the autumn visit spanned September to November 2006 147 
The winter visit was from December 2006 to February 2007 and the spring visit was from March to 148 
May 2007. The original study design for the D-FINES data was to allow comparisons between 149 
vitamin D status between seasons and ethnic-menopausal groups, rather than to assess seasonal 150 
change in detail over the course of the year. Thus for this subsequent analysis, where assessment of 151 
seasonal change was required in more detail, the actual visit date rather than season was used for each 152 
measurement and the data pooled. 153 
In a subgroup of n = 65 women (South Asian, n = 30 and Caucasian, n = 35) (randomly selected from 154 
all the women who had successfully attended all four visits) blood samples were also assessed for the 155 
bone resorption marker serum c-telopeptide (sCTX). In accordance with the ethical standards laid 156 
down in the 1964 Declaration of Helsinki, ethical reviews were obtained from relevant Research 157 
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Ethics Committees (National Health Service NHS REC 06/Q1909/1, and University of Surrey 158 
EC/2006/19/SBMS). Written, informed consent was obtained from all participants.   159 
Biochemical Measurements 160 
Serum CTX was measured using an electrochemiluminescent immunoassay (Roche cobas e411 161 
automated analyser) at the University of Sheffield (Metabolic Bone Centre, Northern General 162 
Hospital, Sheffield, UK). Intra-assay CV was:  5.7% (n = 12, mean 0.19 ng/mL).  Inter assay CV was:  163 
Level 1 QC: 2.1% (n = 9, mean 0.30 ng/mL); Level 2 QC: 3.6% (n = 9, mean 0.70 ng/mL); Level 3 164 
QC: 6.6% (n = 9, mean 2.86 ng/mL). Serum 25(OH)D and sPTH were measured by the Vitamin D 165 
Research Group, University of Manchester as described in detail previously [8]. The laboratory 166 
participates successfully in the Vitamin D quality assurance scheme (DEQAS) and is accredited to 167 
Quality Measurement Standards ISO 9001:2008 and ISO 13485:2003) [8]. Briefly, serum 25(OH)D 168 
was measured using the manual IDS enzyme immunoassay (Immunodiagnostic Systems Ltd, Boldon, 169 
Tyne and Wear, UK) [8]. Manufacturer’s reference ranges were 19-58 ng/mL (48-144 nmol/L) but 170 
vary with season; sensitivity 2 ng/mL (5 nmol/L); intra- and inter-assay coefficients of variation 6% 171 
and 7%, respectively (manufacturer’s values). Serum intact parathyroid hormone (PTH) was 172 
measured using the OCTEIA immunoenzymometric assay (Immunodiagnostic Systems Ltd, Boldon, 173 
Tyne and Wear, UK). The normal adult reference range is 0.8-3.9 pmol/L; sensitivity 0.06 pmol/L; 174 
intra- and inter-assay CV 4% and 6%, respectively (manufacturer’s values) [8]. 175 
Non-Linear Mixed Modelling Analysis 176 
A non-linear mixed modelling approach was used to assess the hypothesis that individuals with a high 177 
degree of seasonal cycling of 25(OH)D would show increased bone resorption, as evidenced by 178 
increased serum c-telopeptide [sCTX] and serum parathyroid hormone [sPTH] concentration. The 179 
25(OH)D data and the sPTH data were not normally distributed so 25(OH)D and sPTH were 180 
logarithmically transformed. The data for sCTX were normally distributed, as assessed by the 181 
Kolmogorov-Smirnov test,  so were not log transformed. Measurements for sPTH, sCTX and 182 
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25(OH)D were approximately equally spaced over a year with precise visit dates used in the analysis, 183 
rather than month or season. Demographic data were drawn from baseline data only.  184 
As potential confounders, at all times, BMI and ethnic-menopausal group were included in the model. 185 
It was important to control for ethnicity and menopausal status as these two factors are also known to 186 
be associated with differences in vitamin D status and vitamin D metabolism. The four ethnic-187 
menopausal subject groups in our dataset were postmenopausal Caucasian, premenopausal Caucasian, 188 
postmenopausal South Asian and premenopausal South Asian and were entered into the model as 3 189 
dummy variables, statistically contrasting the first group (postmenopausal Caucasian) with the 190 
remainder. BMI was entered into the model as it is known to be associated with overall 25(OH)D [17, 191 
27], and seasonal change in 25(OH)D [12].   192 
The modelling procedure was as follows: To investigate constants of proportionality with seasonal 193 
fluctuation in serum 25(OH)D for the first dependent variable (sPTH), the data were analysed for all 194 
the participants who had a complete set of 4 data points for sPTH and log 25(OH)D, as well as 195 
baseline data for BMI and ethnic/menopausal group. This was a total of n =200 women (n=96,n=65, 196 
n=21 and n=18 in postmenopausal Caucasians, premenopausal Caucasians, postmenopausal Asians 197 
and premenopausal Asians respectively). The procedure followed for the sCTX analysis was  198 
analogous to that for sPTH (see above).The equivalent data in this analysis were for n= 60 women 199 
(n=15, n=18, n=15 and n=12 respectively in postmenopausal Caucasians, premenopausal Caucasians, 200 
postmenopausal Asians and premenopausal Asians).  201 
The model was  used to assess whether log sPTH concentration, corrected for confounding effects as 202 
described above,  was proportional to the level of log25(OH)D as well as to the amplitude of seasonal 203 
variation in log 25(OH)D divided by the mesor log 25(OH)D. It was important to adjust the amplitude 204 
by the mean log 25(OH)D concentration (mesor), in order to control for the confounding effects of 205 
overall mean 25(OH)D concentration. The individual participant’s four data points for log 25(OH)D 206 
were modelled as a mean level specific to that participant, to which was added a sine wave of 207 
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amplitude and angular off-set both also specific for that participant, as well as a random normally 208 
distributed error term. The two participant-specific variables, mean level and angular offset were 209 
modelled as mixed random effects with unstructured variance-covariance matrix. 210 
The sPTH data were simultaneously regressed as sets of four within participant repeated measures 211 
(with unstructured variance covariance matrix, also encompassing the effects of the above mentioned 212 
two participant-specific variables) against the independent variables: level of 25(OH)D,  ratio of 213 
amplitude to mean of log 25(OH)D (i.e. amplitude/mesor), ethnicity and menopausal status category 214 
and BMI. The whole procedure was repeated for sCTX as the dependent variable. 215 
The non-linear mixed modelling analysis was conducted using the NLMIXED procedure, of the SAS 216 
(SAS Institute, Cary, NC, USA) software suite. Regression parameters significantly different from 217 
zero within the limits of the conventional 95% confidence interval were deemed statistically 218 
significant. Baseline participant statistics were analysed using PASW Statistics, Release Version 219 
18.0.0 (SPSS Inc., 2009, Chicago IL).   220 
221 
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Results 222 
Participant Characteristics  223 
Results are presented as mean (SD). Table 1 shows the baseline characteristics of the cohort (n=367) 224 
the participants were drawn from, including 25(OH)D, sPTH and sCTX concentration in each season 225 
and anthropometric information. The women had a mean BMI of 26.3Kg/m
2
 (5.1), thus were 226 
classified as overweight.  They also had a mean age of 48.2 (14.4) years and a dietary calcium intake 227 
of 833(308) mg/d. Mean 25(OH)D concentration ranged from 39.4-58.4nmol/L, depending on season.  228 
Concurrently, the ranges of median values for sPTH and mean values for sCTX concentrations by 229 
season were 2.8-3.0pmol/L and 0.33-0.35ng/mL respectively. 230 
Tables 2 and 3 show the same information, but for the subsets of the cohort who were included in the 231 
sPTH and sCTX analyses due to having complete data for all relevant variables(n=200, sPTH; n=60, 232 
sCTX).  As can be seen from comparing table 1 (entire cohort) with that of table 2 (sPTH analysis) 233 
and table 3 (sCTX analysis), the women included in the sPTH and sCTX analyses were representative 234 
of the entire cohort.  They had similar age (48.2 (14.4) vs. 50.6(12.9) vs. 47.7(12.4)y), BMI  (26.4 235 
(5.1) vs. 26.2 (4.7) vs. 26.0 (4.1) Kg/m
2
) and dietary calcium intake (833(308) vs. 862(329) vs. 236 
857(417) mg/d) to that of the original cohort. Also, for the sPTH analysis, mean 25(OH)D  (59.2-38.1 237 
nmol/L vs. 58.4-38.3nmol/L; see tables 1-2 for confidence intervals) and median sPTH concentrations 238 
(2.8-3.0 pmol/L vs. 2.8-3.0pmol/L) were similar to that of the whole cohort. For the sCTX analysis, 239 
mean 25(OH)D was slightly lower (47.8-33.9nmol/L vs. 58.4-38.4nmol/L; see tables 1 and 3 for 240 
confidence intervals) and median sPTH the same (2.8-3.0 pmol/L) between the participants in the 241 
regression model and the whole cohort.This result for 25(OH)D was likely due to a more even split of 242 
South Asian and Caucasian women in the sCTX analysis.  This is in contrast to the sPTH analysis 243 
whereby there were a higher number of Caucasians than South Asians. 244 
TABLE 1 ABOUT HERE 245 
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TABLE 2 ABOUT HERE 246 
TABLE 3 ABOUT HERE 247 
Non-Linear Mixed Modelling 248 
The regression analysis is summarised in Table 4.  Table 4 includes the effect sizes for the main 249 
model parameters, here defined as the absolute value of the quotient of the estimated value and the 250 
standard error.  Thus defined, the effect size for a parameter is only an indication of how significantly 251 
different from 0 the value of the parameter is, i.e. it is an indication of how necessary it is to include, 252 
as opposed to excluding, that parameter in the model. However, apart from identifying the importance 253 
of including the parameter in the model, the effect size conveys no other information about the 254 
functioning of the model.   255 
 256 
TABLE 4 ABOUT HERE 257 
 258 
sPTH and sCTX Analysis 259 
 260 
For log sPTH, the regression coefficient (and SE) for the amplitude/mesor ratio of 25(OH)D were 261 
0.057 (0.003) with a  95% confidence interval (0.051, 0.063); p<0.0001.  The effect size was 19.0, 262 
which means that the estimated value for that parameter was 19 standard errors of the estimate 263 
removed from 0. This shows a significant positive relationship, after adjustment for confounders 264 
(BMI and ethnic/menopausal group), and indicates that the amplitude/mesor parameter for 25(OH)D 265 
was a significant predictor of  log sPTH concentration. For sPTH the regression coefficient (SE) for 266 
the level of 25(OH)D was -0.018 (0.001) with a 95% confidence interval of (-0.020, -0.016); 267 
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p<0.0001. The effect size was 18.0, marginally smaller than for the coefficient referred to 268 
immediately above. 269 
 270 
For sCTX, the regression coefficient for amplitude/mesor ratio of 25(OH)D had an estimated value of 271 
0.528 (95% confidence interval 0.418, 0.638; p=<0.0001) which was also statistically significant so 272 
that conclusions analogous to the above follow. The effect size was 9.3, which means that the 273 
estimated value for that parameter is 9.3 standard errors of the estimate removed from 0.   274 
For sCTX the regression coefficient (SE) for the level of 25(OH)D was -0.105 (0.014) with a 95% 275 
confidence interval of (-0.132,- 0.078); p<0.0001. The effect size was 7.5, marginally smaller than 276 
that for the coefficient referred to immediately above. 277 
 278 
Post-hoc Power Considerations 279 
One of the objectives of the study was to investigate the relationship between sPTH and the seasonal 280 
variation in serum 25(OH)D and the study results show power in excess of 99.9% for this aim, 281 
adjusting for confounding effects.Another of the objectives of the study was to investigate the 282 
relationship between sCTX and the seasonal variation in serum 25(OH)D and the study results also 283 
show power in excess of 99.9% for this aim, adjusting for confounding effects.   284 
 285 
   286 
 287 
288 
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Discussion 289 
This is the first study, to the authors’ knowledge, that has examined the association between seasonal 290 
change in 25(OH)D and a marker of bone resorption. A significant positive relationship was observed 291 
between the seasonal change in 25(OH)D and sPTH, supporting our original hypothesis suggesting 292 
that those individuals with a higher seasonal change in 25(OH)D had a higher sPTH. There was also a 293 
statistically significant association between seasonal change in 25(OH)D and bone resorption, as 294 
measured by sCTX, so that similar conclusions to the above are applicable.   295 
The above findings suggest that the higher sPTH seen with increased seasonal change in 25(OH)D 296 
may translate into alterations in bone resorption. Indeed, the result for sCTX are not  surprising. A 297 
concomitant increase in sCTX would be predicted due to the increased bone resorption implicated by 298 
increased sPTH levels. The trends observed for sPTH and sCTX in the current study lend support to 299 
Vieth’s hypothesis[14]  that large seasonal changes in 25(OH)D might  be associated with some 300 
adverse health outcomes,. Indeed, in this study, for both sPTH and sCTX, seasonal fluctuation (as 301 
expressed by the amplitude/mesor ratio) had an (albeit marginally) larger predictive ability in 302 
explaining sPTH and sCTX than did the average concentration of 25(OH)D (as assessed by respective 303 
coefficient effect sizes).  Thus, in this dataset, seasonal variation in 25(OH)D status had a marginally 304 
statistically more significant impact on sPTH and sCTX concentration than did overall 25(OH)D 305 
concentration. 306 
 307 
It is important to know if seasonal cycling of 25(OH)D is detrimental to health, in order to inform 308 
supplementation advice for vitamin D. Specifically, it raises the question of whether year round 309 
supplementation of vitamin D, or winter only supplementation should be recommended. The clinical 310 
and public health implications of this study are the suggestion that wintertime only supplementation 311 
may be beneficial in order to blunt the rhythm of 25(OH)D, keeping 25(OH)D levels consistent 312 
throughout the year. In addition, it is essential to understand seasonal variation in 25(OH)D to assist 313 
in the interpretation of some of the adverse effects reported in the literature in regard to high serum 314 
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concentrations of 25(OH)D.  Specifically, it is crucial to separate the effects of high levels of 315 
25(OH)D per se from those of seasonal variation in order to establish guidelines for optimal 25(OH)D 316 
concentrations, which remain a topic of ongoing debate in the vitamin D field. Findings from the 317 
current study suggest that seasonal variation, as well as the overall concentration, of 25(OH)D needs 318 
to be considered when assessing optimal vitamin D status.  319 
A limitation of the study findings is that they are generalisable only to Caucasian and South Asian 320 
women, and may not be generalisable to other ethnic groups due to potential differences in vitamin D 321 
metabolism that may affect seasonal changes in 25(OH)D, sPTH and sCTX. A larger sample size for 322 
bone markers will be even more informative to clarify the relationship between seasonal fluctuation in 323 
25(OH)D and bone resorption.  324 
In future work, it will be important to assess markers of bone formation as well as resorption as  325 
overall bone turnover is important for bone health, not just bone resorption. It is possible that an 326 
increase in sPTH may trigger increased bone formation, so may not necessarily be detrimental to bone 327 
health.  Measurement of bone formation as well as bone resorption is required to investigate further 328 
whether an increase in sPTH is likely to be harmful in the longer term. It would also be useful in 329 
longitudinal research studies to assess whether structural changes in bone are associated with seasonal 330 
changes in 25(OH)D, in order to determine possible chronic effects on bone health. Indeed, even if 331 
seasonal fluctuation in 25(OH)D is detrimental to the activity of the bone vitamin D hydroxylase 332 
enzymes, there could still be physiological adaptation to this in the long term.  333 
334 
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 335 
Conclusions  336 
This study shows that greater seasonal cycling of 25(OH)D is associated with increased sPTH 337 
concentration and with increased bone resorption. In terms of public health, this finding suggests 338 
vitamin D supplements should not necessarily be taken all year round and there may be justification  339 
for ‘blunting’ the rhythm of 25(OH)D concentration over the course of the year via wintertime only 340 
supplementation. Furthermore, it suggests seasonal variation in 25(OH)D, as well as overall 341 
concentration, should be considered when making recommendations as to optimal concentrations of 342 
25(OH)D for health.  343 
344 
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Tables  431 
Table 1. Characteristics of participants in D-FINES cohort (n=367)≠ 432 
 N Mean SD 
Lower 
95% CI 
Upper 
95% CI 
Age (years) 367 48.2 14.4 19.98 76.42 
Body Mass Index (BMI) (kg/m
2
) 365 26.4 5.1 16.40 36.40 
Weight (kg) 365 69.6 12.7 44.71 94.49 
Height (m) 365 1.6 0.1 1.40 1.80 
Dietary calcium (mg)± 286 833 308 229.32 1436.68 
Summer 25(OH)D (nmol/L) 346 58.4 27.1 5.28 111.52 
Autumn 25(OH)D (nmol/L) 281 51.1 24.7 2.69 99.51 
Winter 25(OH)D (nmol/L) 253 38.4 18.0 3.12 73.68 
Spring 25(OH)D nmol/L 248 42.7 22.0 -0.42 85.82 
Summer sCTX ng/mL 65 0.34 0.16  0.03 0.65 
Autumn sCTX ng/mL 65 0.34 0.15  0.05 0.63 
Winter sCTX ng/mL 65 0.33 0.15  0.04 0.62 
Spring sCTX ng/mL 65 0.35 0.16  0.04 0.66 
 N Median 25
th*
 75
th*
 IQR 
Summer sPTH pmol/L 345 2.8 2.0 3.6 1.6 
Autumn sPTH pmol/L 291 2.8 2.0 3.8 1.8 
Winter sPTH pmol/L 244 3.0 2.1 3.8 1.7 
Spring sPTH pmol/L 258 2.8 2.0 3.6 1.6 
sPTH=serum parathyroid hormone; sCTX=serum C-telopeptide of collagen; 25(OH)D=serum 25-433 
hydroxyvitamin D; summer to winter 25(OH)D ratio=winter 25(OH)D-summer 25(OH)D; n=number of 434 
participants with measurement, ≠ n=144,n=135, n=42 and n=46 in postmenopausal Caucasians, premenopausal 435 
Caucasians, postmenopausal Asians and premenopausal Asians respectively. ±Dietary calcium was assessed 436 
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using four-day photograph assisted diet diaries (as previously validated in the EPIC cohort)*percentile, 437 
IQR=interquartile range 438 
439 
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Table 2. Characteristics of participants- (n=200) in the sPTH analysis≠ 440 
 N Mean SD 
Lower 
95% CI 
Upper 
95% CI 
Age (years) 200 50.6 12.9 25.32 75.88 
Body mass index (BMI) (Kg/m
2
) 200 26.2 4.7 16.99 35.41 
Weight (kg) 200 68.8 12.0 45.28 92.32 
Height (m) 200 1.62 0.06 1.50 1.74 
Dietary calcium (mg) 186 862 329 217.16 1506.84 
Summer 25(OH)D (nmol/L) 200 59.2 27.7 4.91 113.49 
Autumn 25(OH)D (nmol/L) 200 50.7 24.3 3.07 98.33 
Winter 25(OH)D nmol/L 200 38.1 17.5 3.80 72.40 
Spring 25(OH)D nmol/L 200 43.1 22.5 -1.00 87.20 
Summer sCTX ng/mL 59 0.34 0.16 0.03 0.65 
Autumn sCTX ng/mL 59 0.34 0.16 0.03 0.65 
Winter sCTX ng/mL 59 0.33 0.16 0.02 0.64 
Spring sCTX ng/mL 59 0.36 0.17 0.03 0.69 
 N Median 25
th*
 75
th*
 IQR 
Summer sPTH pmol/L 200 2.90 2.00 3.70 1.7 
Autumn sPTH pmol/L 200 2.80 2.00 3.70 1.7 
Winter sPTH pmol/L 200 3.00 2.10 3.80 1.7 
Spring sPTH pmol/L 200 2.80 2.00 3.60 1.6 
sPTH=serum parathyroid hormone; sCTX=serum C-telopeptide of collagen; 25(OH)D=serum 25-hydroxyvitamin D; 441 
summer to winter 25(OH)D ratio=winter 25(OH)D-summer 25(OH)D, n=number of participants with measurements 442 
≠ n=96,n=65, n=21 and n=18 in postmenopausal Caucasians, premenopausal Caucasians, postmenopausal Asians and 443 
premenopausal Asians respectively. ±Dietary calcium was assessed using four-day photograph assisted diet diaries (as 444 
previously validated in the EPIC cohort), * percentile, IQR=interquartile range 445 
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Table 3. Characteristics of participants- (n=60) in the sCTX analysis≠ 446 
 N Mean SD 
Lower 
95% CI 
Upper 
95% CI 
Age (years) 60 47.7 12.4 23.40 72.00 
Body mass index (BMI) (kg/m
2
) 60 26.0 4.1 17.96 34.04 
Weight (kg) 60 66.5 10.1 46.70 86.30 
Height (m) 60 1.60 0.06 1.48 1.72 
Dietary calcium (mg)± 52 857 417 39.68 1674.32 
Summer 25(OH)D (nmol/L) 60 47.8 25.3 -1.79 97.39 
Autumn 25(OH)D nmol/L 60 41.2 25.3 -8.39 90.79 
Winter 25(OH)D nmol/L 60 33.9 20.4 -6.08 73.88 
Spring 25(OH)D nmol/L 60 36.9 20.9 -4.06 77.86 
Summer sCTX ng/mL 60 0.34 0.16 0.03 0.65 
Autumn sCTX ng/mL 60 0.34 0.16 0.03 0.65 
Winter sCTX ng/mL 60 0.33 0.16 0.02 0.64 
Spring sCTX ng/mL 60 0.35 0.17 0.02 0.68 
 N Median 25
th*
 75
th*
 IQR 
Summer sPTH pmol/L 60 3.10 2.10 3.88 1.78 
Autumn sPTH pmol/L 60 3.10 2.40 3.98 1.58 
Winter sPTH pmol/L 59 3.20 2.30 4.40 2.10 
Spring sPTH pmol/L 60 3.20 1.95 4.00 2.05 
sPTH=serum parathyroid hormone; sCTX=serum C-telopeptide of collagen; 25(OH)D=serum 25-hydroxyvitamin D; 447 
summer to winter 25(OH)D ratio=winter 25(OH)D-summer 25(OH)D; n=number of participants with measurements  448 
≠n=15, n=18, n=15 and n=12 in postmenopausal Caucasians, premenopausal Caucasians, postmenopausal Asians and 449 
premenopausal Asians respectively ±Dietary calcium was assessed using four-day photograph assisted diet diaries (as 450 
previously validated in the EPIC cohort) *percentile, IQR=interquartile range 451 
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 452 
Table 4 - Relevant non-linear  modelling parameter statistics for sPTH and sCTX 453 
 sPTH  n=200
≠
  sCTX  n=60
±
  
Parameter 
Estimate 
 
(Beta) 
SE 95% CI 
p Effect 
size¥ 
Estimate 
 
(Beta) 
SE 95% CI 
p Effect 
size¥ 
Indicator (0 1) variable 
for (PRE C) v (POST 
C))* 
 
(PRE C) v (POST C)* 
-0.092 
 
0.121 
0.037 
0.121 
(-0.165; -
0.019) 
 
(-0.564;     
-0.090) 
0.0123 
 
0.0069 
2.5 -0.205 0.080 (-0.362; -
0.048) 
0.0109 2.6 
Indicator (0 1) variable 
for (POST A)v(POST 
C) 
(POST SA) v (POST 
C)* 
0.511 
0.475 
0.048 
0.164 
(0.417; 
0.605) 
 
(0.154; 
0.796) 
<.0001 
 
0.0038 
10.6 0.181 0.080 (-0.338; -
0.024) 
0.0242 2.3 
Indicator (0 1) variable 
for (PRE A)v(POST 
C) 
 (PRE SA) v (POST 
C)*  
0.052 
 
0.427 
0.066 
 
0.563 
(-0.077; 
0.181) 
 
(-0.676; 
1.530) 
0.4327 
 
0.4482 
0.8 0.070 0.048 (-0.024; 
0.164) 
0.1406 1.5 
BMI (Body mass 
index) kg/m
2
 
0.037 
 
0.037 
0.002 
 
 
 
( . 33; 
0.041) 
 
(0.010; 
0.064) 
<.0001 
 
0.0082 
18.5 0.007 0.005 (-0.003;  -
0.017) 
0.1389 1.4 
25(OH)D regression 
coefficient 
-0.018 0.001 (-0.02 ;-
0.016) 
<.0001 18.0 -0.105 0.014 (-0.132;-
0.078) 
<.0001 7.5 
25(OH)D Ratio 
(amplitude/mesor) 
0.057 
 
8.152 
0.003 
 
0.690 
(0.051; 
0.063) 
 
(6.800; 
9.504) 
<0.000
1 
19.0 0.528 0.056 (0.418; 
0.638) 
<.0001 9.3 
-2 log likelihood 
1330.7 
 
2028.66 
 292.0  
 454 
*POST C= Postmenopausal Caucasian (reference group); PRE C = Premenopausal Caucasian; POST SA = Postmenopausal 455 
South Asian, PRE SA= Premenopausal South Asian. ** Body Mass Index.  ≠ n=96,n=65, n=21 and n=18 in postmenopausal 456 
Caucasians, premenopausal Caucasians, postmenopausal Asians and premenopausal Asians respectively. ± n=15, n=18, 457 
n=15 and n=12 in postmenopausal Caucasians, premenopausal Caucasians, postmenopausal Asians and premenopausal 458 
Asians respectively 459 
¥Definition of effect sizes: the absolute value of the quotient of the estimated value and the standard error, Thus defined, the 460 
effect size for a parameter is only an indication of how significantly different from 0 the value of the parameter is, i.e. it is an 461 
indication of how necessary it is to include, as opposed to excluding, that parameter in the model. The conventional 5% 462 
significance level is met for a parameter when the effect size for that parameter meets or exceeds a value of 1.96. However, 463 
apart from identifying the importance of including the parameter in the model, the  effect size conveys no other information 464 
about the functioning of the model.   465 
 466 
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